$1,000 invested Gilead Sciences Inc. (2021)
NASDAQ · GILD · reinvest dividends · adjusted close
●Result2021-01-04 — 2026-10-15
Today you would have
$3,190
+$2,190 (+219.01%)
GILDSPY (benchmark)
- Entry price
- $49.33
- Current price
- $157.37
- Shares
- 20.2715
- CAGR
- +22.24%
- Max Drawdown
- -26.59%
- vs SPY
- +94.21 pp
✦The story
Investing $1,000 in Gilead Sciences at the start of 2021 would have grown to $3,190 by mid-2026, a total return of +219.0%. The company entered the period known for its antiviral drugs, including treatments used during the COVID-19 pandemic, and later saw its shares re-rate higher. That beat the S&P 500's +124.8% over the same years.
#Related scenariosfor comparison
Other years for GILD